new version V2017

Losartan angiotensin-receptor blockers

Losartan Monopotassium Salt - Losartan Potassium - DuP753 - DuP 753 - DuP-753 - MK954 - MK 954 - MK-954 - Cozaar - Losartan      

pdf
TrialStudied treatmentControl treatmentpatientsROBResultNCT

acute myocardial infarction

OPTIMAAL, 2002LosartanCaptoprilSuggesting

atrial fibrillation

LIFE (AF ancillary study), 2005losartanatenololSuggesting

diabetes type 2

RENAAL, 2001losartanplacebo Low risk of bias Suggesting
LIFE (diabetic subgroup), 2002losartanatenolol Exploratory Suggesting

diabetic kidney disease

RENAAL, 2001losartanplacebo Low risk of bias Suggesting

heart failure

Dickstein et al., 1995losartanenalapril Exploratory -
Losartan Phase III U.S., 1995losartanplacebo Exploratory Negative
Losartan phase II S, 1996losartanenalapril Exploratory -
losartan phase II US, 1996losartanenalapril Exploratory -
Losartan Phase III International, 1996losartanplacebo Exploratory Suggesting
ELITE, 1997losartancaptopril Exploratory Negative
Lang et al., 1997losartanenalapril Exploratory -
Hamroff et al., 1999losartan+ACE inhibitorACE inhibitor only Exploratory -
ELITE II, 2000losartancaptopril Low risk of bias -
HEAAL, 2009losartan 150mglosartan 50mg Low risk of bias SuggestingNCT00090259
NCT00090259 ongoing losartanlosartan - NCT00090259

hypertension

ELITE, 1997LosartanCaptopril Exploratory Suggesting
ELITE-II, 2000LosartanCaptopril Low risk of bias Negative
OPTIMAAL, 2001LosartanCaptopril Risk of bias Negative
RENAAL, 2001losartanplacebo Low risk of bias Suggesting
RENAAL, 2001losartanplacebo Low risk of bias -
LIFE, 2002losartanatenolol Low risk of bias Suggesting
LIFE (diabetic subgroup), 2002losartanatenolol Exploratory Suggesting

miscellaneous

RENAAL, 2001losartanplacebo Low risk of bias -
LIFE, 2002losartanatenolol Low risk of bias Suggesting

patients at high risk for cardiovascular events

RENAAL, 2001losartanplacebo Low risk of bias -
LIFE, 2002losartanatenolol Low risk of bias Suggesting